Second-line chemotherapy with capecitabine (Xeloda) and docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial (Q48825323)
Jump to navigation
Jump to search
scientific article published on 29 April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Second-line chemotherapy with capecitabine (Xeloda) and docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial |
scientific article published on 29 April 2010 |
Statements
1 reference
Second-line chemotherapy with capecitabine (Xeloda) and docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial (English)
1 reference
Ourania Katopodis
1 reference
Aris Polyzos
1 reference
Nikolaos Kentepozidis
1 reference
Stylianos Giassas
1 reference
Maria Rovithi
1 reference
Vasiliki Bozionelou
1 reference
Kostas Kalbakis
1 reference
Lambros Vamvakas
1 reference
Dimitris Mavroudis
1 reference
Vassilis Georgoulias
1 reference
29 April 2010
1 reference
67
1 reference
2
1 reference
361-368
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference